1. Home
  2. WST vs PKX Comparison

WST vs PKX Comparison

Compare WST & PKX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • PKX
  • Stock Information
  • Founded
  • WST 1923
  • PKX 1968
  • Country
  • WST United States
  • PKX South Korea
  • Employees
  • WST N/A
  • PKX N/A
  • Industry
  • WST Medical/Dental Instruments
  • PKX Steel/Iron Ore
  • Sector
  • WST Health Care
  • PKX Industrials
  • Exchange
  • WST Nasdaq
  • PKX Nasdaq
  • Market Cap
  • WST 20.1B
  • PKX 15.4B
  • IPO Year
  • WST N/A
  • PKX 1994
  • Fundamental
  • Price
  • WST $268.74
  • PKX $51.60
  • Analyst Decision
  • WST Strong Buy
  • PKX
  • Analyst Count
  • WST 9
  • PKX 0
  • Target Price
  • WST $354.50
  • PKX N/A
  • AVG Volume (30 Days)
  • WST 786.8K
  • PKX 139.1K
  • Earning Date
  • WST 10-23-2025
  • PKX 10-27-2025
  • Dividend Yield
  • WST 0.32%
  • PKX 2.04%
  • EPS Growth
  • WST 0.17
  • PKX N/A
  • EPS
  • WST 6.75
  • PKX 4.24
  • Revenue
  • WST $3,017,900,000.00
  • PKX $49,844,200,539.00
  • Revenue This Year
  • WST $6.97
  • PKX N/A
  • Revenue Next Year
  • WST $6.11
  • PKX $4.11
  • P/E Ratio
  • WST $40.15
  • PKX $41.43
  • Revenue Growth
  • WST 4.92
  • PKX N/A
  • 52 Week Low
  • WST $187.43
  • PKX $39.40
  • 52 Week High
  • WST $348.90
  • PKX $61.24
  • Technical
  • Relative Strength Index (RSI)
  • WST 45.27
  • PKX 45.58
  • Support Level
  • WST $262.48
  • PKX $52.35
  • Resistance Level
  • WST $287.98
  • PKX $55.12
  • Average True Range (ATR)
  • WST 11.61
  • PKX 1.17
  • MACD
  • WST -2.16
  • PKX -0.27
  • Stochastic Oscillator
  • WST 10.45
  • PKX 10.79

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About PKX POSCO Holdings Inc.

POSCO Holdings Inc is a holding company and operates through its subsidiaries. The company operates across four distinct segments. The first segment is the Steel Segment, which includes the production and sale of steel products. The second segment is the Infrastructure Business, which is further divided into three operations. The Trading Segment comprises trading and natural resource development activities. The Construction Segment involves the planning, designing, and construction of industrial plants, civil engineering projects, and buildings. The Logistics and Others Segment. The third segment is the Secondary Battery Materials Segment, and the fourth segment is the Others Segment.

Share on Social Networks: